SLC6A19抗体

The SLC6A19 antibody is a crucial tool for studying the solute carrier family 6 member 19 (SLC6A19), a sodium-dependent neutral amino acid transporter predominantly expressed in the kidney and intestinal epithelium. This transmembrane protein facilitates the reabsorption of neutral amino acids, such as leucine and tryptophan, from renal filtrate and dietary sources, playing a vital role in maintaining amino acid homeostasis. Research on SLC6A19 has gained attention due to its association with metabolic disorders, including type 2 diabetes and obesity, as well as Hartnup disorder, an inherited condition linked to impaired amino acid transport. The SLC6A19 antibody enables the detection, localization, and quantification of this transporter in tissues and cell lines using techniques like Western blotting, immunohistochemistry, and immunofluorescence. Validated antibodies help investigate its regulation under physiological or pathological conditions, such as dietary changes, metabolic stress, or genetic mutations. Recent studies also explore SLC6A19 as a potential therapeutic target, with inhibitors under investigation for modulating amino acid uptake in metabolic diseases. High specificity and proper validation (e.g., knockout controls) are essential to ensure reliable experimental outcomes, given the protein’s structural similarities to other SLC6 family members.